Viewing Study NCT04239469


Ignite Creation Date: 2025-12-24 @ 10:57 PM
Ignite Modification Date: 2026-06-06 @ 5:37 PM
Study NCT ID: NCT04239469
Status: UNKNOWN
Last Update Posted: 2020-01-27
First Post: 2020-01-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment.
Sponsor: Knop Laboratorios
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fibromyalgia View
None Cannabis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cannabis View
None fibromyalgia View
None phytocannabinoids View
None cannabinoid View